8th EPP Life Sciences Pricing Forum, 2018 Montreux
13:00 - 17:00
In its 8th year, our EPP Life Science Pricing Forum (3-5 Oct. Montreux – Switzerland) will once again bring together the best industry's speakers, senior executives and innovators to discuss the latest developments in the pricing, market access and profit optimisation area.
This year's forum is completely re-designed to cover the most up to date pricing and market access real-world insights, trends and real case studies with information not available in any other event. The forum offers 3 interactive days with workshops, expert presentations, panel sessions, roundtables, a great evening event and many more networking activities.
Our event year by year gathers a high motivated audience of industry leaders from around the world, with 120+ decision makers focused on pricing, market access and profit optimisation for Life Sciences, on Pharma and MedTech. Bringing the latest challenges and developments in the pricing and profit optimisation world.
5 reasons to attend the Forum in 2018:
1. 120+ senior level executives come together for exclusive keynote presentations, 2 breakouts on Pharma and MedTech, workshops and unrivalled networking to engage in high level business discussions that will shape the future of pricing
2. The Forum agenda was created together with key industry influencers and will include interactive workshops with Pharma and MedTech tracks
4. Discuss, learn and challenge both strategic and tactical topics
5. Networking: you will meet and do business with the leading industry leaders, innovators and experts to discuss the issues of the fast-growing Pharma and MedTech industries
Our goal is to provide the most interactive and pioneering content forum, deeply detailed, in a setting with your industry peers where you will be able to network, learn and discuss about pricing strategy, payers' relationships, price policy and innovative pricing tools.
If you would like to participate as delegate, sponsor or exhibitor, contact us: email@example.com
Passes start from: EUR 1295.0
Speakers: Ana Cespedes, PharmD, MBA – Senior Vice President, Global Marketing and Strategy - Merck KGaA , Scott Murrie - PhD - General Manager, Global Pricing - GE Healthcare , Alan Crowther, President of Global Markets, Alliance Life Sciences, Slobodan Farago - Commercial Excellence Manager MDS Europe – BD, Dr. Vivian Mendonca - Regional Director - Oncology Access and Pricing - EMEAC (Europe, Middle East, Africa, Canada) – MSD , Halima Benghabrit - Global Pricing Head of Established Products - Sanofi, Daniel Cho - Director Marketing, Global Pricing and Competitive Portfolio Analytics - Philips Healthcare , Maarten Van Baelen, Market Access Director – Medicines for Europe , George Boretos, CMO, Cube RM, Gulen Desteli, Global Pricing Manager - GE Healthcare , Francis Arickx - Advisor General. Head of Directorate. Directorate Pharmaceutical Policy. Health Care Department - National Institute for Health and Disability Insurance (RIZIV INAMI) , Richard Charter | Head of Market Access and Pricing Diabetes Care EMEA, BD , Diar Fattah - Associate Director of Medicines Optimisation - NHS / NICE , Libor Minichbauer - Head of Pricing and Payer Programs - Novartis Oncology Region EGM, Ruven Remo Eul, Director, Life Sciences, HighPoint Solutions , Luca Morreale, Senior Manager, Life Sciences, HighPoint Solutions , Jörg Mahlich, Head of Health Economics and Outcomes Research, Janssen pharmaceutical , Dr. Marco Penske - Head Market Access and Healthcare Affairs - Boehringer Ingelheim , Mukarram Bhaiji - Director, Global Pricing Strategy - Smith and Nephew